Development of tubulin inhibitors as antimitotic agents for cancer therapy

Studies in Natural Products Chemistry

Volumn 33, Issue PART M, 2006, Pages 719-750

  Mahboobi, S ^a   Sellmer, A ^a   Beckers, T ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957777278     PISSN: 15725995     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1572-5995(06)80038-4     Document Type: Chapter

References (121)

1. Malumbres M., and Barbacid M. Nature Rev Cancer 1 (2001) 222-231
2. Downing K.H. Annu Rev Cell Dev Biol 16 (2000) 89-111
3. Jordan M.A., and Wilson L. Nature Rev, Cancer 4 (2004) 253-265
4. Max M.A. Exp Opin on Ther Patents 12 (2002) 769-776
5. Uckun F.M., Sudbeck E.A., Mao C., Ghosh S., Liu X.P., Vassilev A.O., Navara C.S., and Narla R.K. Curr Cancer Drug Targets 1 (2001) 59-71
6. Uckun F.M. Curr Pharm Design 7 (2001) 1627-1639
7. Uckun F.M., Mao C., Jan S.T., Huang H., Vassilev A.O., Sudbeck E.A., Navara C.S., and Narla R.K. Curr Opin Investig Drugs 1 (2000) 252-256
8. Sharp D.J., Rogers G.C., and Scholey J.M. Nature 407 (2000) 41-47
9. Nicklas R.B. Science 275 (1997) 632-637
10. Desai A., and Mitchison T.J. Annu Rev Cell Dev Biol 13 (1997) 83-117
11. Amos L.A. Curr Opin Struct Biol 10 (2000) 236-241
12. Maccioni R.B., and Cambiazo V. Physiol Rev 75 (1995) 835-864
13. Mahboobi S., Pongratz H., Hufsky H., Hockemeyer J., Frieser M., Lyssenko A., et al. J Med Chem 44 (2001) 4535-4553
14. Hastie S.B. Pharmacol Ther 57 (1991) 377-401
15. and lit. cited there. Jordan A., Hadfield J.A., Lawrence N.J., and Mcgown A.T. Inc Med Res Rev 18 (1998) 259-296
16. Lin C.M., Ho H.H., Petitt G.R., and Hamel E. Biochemistry 28 (1989) 6984-6991
17. and lit. cited there. Shi Q., Chen K., Morris-Natschke S.L., and Lee K.H. Curr Pharm Design 4 (1998) 219-248
18. Angerer E. Exp Opin Ther Patents 9 (1999) 1069-1081
19. Guan J., Zhu X.-K., Brossi A., Tachibana Y., Bastow K., Verdier-Pinard P., Hamel E., Mcphail A.T., and Lee K.-H. Collect Czech Chem Commun 64 (1999) 217-228
20. Goto H., Yano S., Zhang H., Matsumori Y., Ogawa H., Blakey D.C., and Sone S. Cancer Res 62 (2002) 3711-3715
21. Blakey D.C., Westwood F.R., Walker M., Hughes G.D., Davis P.D., Ashton S.E., and Ryan A.J. Clin Cancer Res 8 (2002) 1974-1983
22. Abstract 439. Radema S.A., Beerepoot L.V., Witteveen P.O., Gebbink M.F., Wheeler C., and Voest E.E. ASCO Meeting (2002)
23. Abstract 438. Gadgeel S.M., Lorusso P.M., Wozniak A.J., and Wheeler C. ASCO Meeting (2002)
24. Wang Z., Yang D., Mohanakrishnan A.K., Fanwick P.E., Nampoothiri P., Hamel E., and Cushman M. J Med Chem 43 (2000) 2419-2429
25. Brueggemeier R.W., Bhat A.S., Lovely C.J., Coughenour H.D., Joomprabutra S., Weitzel D.H., Vandre D.D., Yusuf F., and Burak Jr. W.E. J Steroid Biochem and Mol Biol (2001) 145-156
26. Reiser F., Way D., Bernas M., Witte M., and Witte C. Proc Soc Exp Biol Med 279 (1998) 211-216
27. Cushman M., Mohanakrishnan A.K., Hollingshead M., and Hamel E. J Med Chem 45 (2002) 4748-4754
28. Hamel E., and Lin C.M. Biochem Pharmacol 32 (1983) 3864-3867
29. Pettit G.R., Grealish M.P., Herald D.L., Boyd M.R., Hamel E., and Pettit R.K. J Med Chem 43 (2000) 2731-2737
30. Fürstner A., and Nikolakis K. Liebigs Ann (1996) 2107-2113
31. Li Q., Sham H.L., and Rosenberg S.H. Annual Reports in Medicinal Chemistry 34 (1999) 139-148
32. Lin C.M., Singh S.B., Chu P.S., Dempcy R.O., Schmidt J.M., Pettit G.R., and Hamel E. Mol Pharmacol 34 (1988) 200-208
33. Medarde M., Ramos A., Caballero E., Pelaez-Lamamie de Clairac R., Lopez J.L., Gravalos D.G., and Feliciano A.S. Eur J Med Chem 33 (1998) 71-77
34. Tozer G.M., Prise V.E., Wilson J., Locke R.J., Vojnovic B., Stratford M.R., Dennis M.F., and Chaplin D.J. Cancer Res 59 (1999) 1626-1634
35. Griggs J., Metcalfe J.C., and Hesketh R. Lancet Oncol 2 (2001) 82-87
36. Dowlati A., Robertson K., Cooney M., Petros W.P., Stratford M., Jesberger J., et al. Cancer Res 62 (2002) 3408-3416
37. Gaukroger K., Hadfield J.A., Hepworth L.A., Lawrence N.J., and Mcgown A.T. J Org Chem 66 (2001) 8135-8138
38. Szczepankiewicz B.G., Liu G., Jae H.S., et al. J Med Chem 44 (2001) 4416-4430
39. Li Q., Woods K.W., Claiborne A., et al. Bioorg Med Chem Lett 12 (2002) 465-469
40. [40] Ikeda S et al (Kyowa Hakko Kogyo Co. Ltd.) Propenone derives. JP 96277242.
41. [41] Ikeda S et al (Kyowa Hakko Kogyo Co. Ltd.) Propenone derives. WO 9514003.
42. in press. Liou J.-P., Chang J.-Y., Chang C.-W., Chang C.-Y., Mahindroo N., Kuo F.-M., and Hsieh H.-P. J. Med. Chem. (2004)
43. Medarde M., Ramos A.C., Caballero E., de Clairac R.P.L., Lopez J.L., Gravalos D.G., and Feliciano A.S. Bioorg Med Chem Lett 9 (1999) 2303-2308
44. [44] Baylor Univ. : WO9839323: 1998.
45. Gastpar R., Goldbrunner M., Marko D., and von Angerer E. J Med Chem 41 (1998) 4965-4972
46. Goldbrunner M., Loidl G., Polossek T., Mannschreck A., and von Angerer E. J Med Chem 40 (1997) 3524-3533
47. Bacher G., Nickel B., Emig P., et al. Cancer Res 61 (2001) 392-429
48. Lin C.M., and Hamel E. J Biol Chem. 256 (1981) 9242-9245
49. Duanmu C., Lin C.M., and Hamel E. Biochim Biophys Ada 881 (1986) 113-123
50. Beckers T., Reissmann T., Schmidt M., Burger A.M., Fiebig H.H., Vanhoefer U., et al. Cancer Res 62 (2002) 3113-3119
51. Hour M.J., Huang L.J., Kuo S.C., Xia Y., Bastow K., Nakanishi Y., Hamel E., and Lee K.H. J Med Chem 43 (2000) 4479-4487
52. Xia Y., Yang Z.-Y., Xia P., Hackl T., Hamel E., Mauger A., Wu J.-W., and Lee K.-H. J Med Chem 44 (2001) 3932-3936
53. Lee K.-H. J Biomed Sci 6 (1999) 236-250
54. Xia Y., Yang Z.Y., Morris-Natschke S.L., and Lee K.H. Curr Med Chem 6 (1999) 179-194
55. Yoshimatsu K., Yamaguchi A., Yoshino H., Koyanagi N., and Kitoh K. Cancer Res 57 (1997) 3208-3213
56. Yamamoto K., Noda K., Yoshimua A., et al. Cancer Chemother Pharmacol 42 (1998) 127-134
57. Owa T., Yokoi A., Yamazaki K., Yoshimatsu K., Yamori T., and Nagasu T. J Med Chem 45 (2002) 4913-4922
58. Gwaltney II S.L., Imade H.M., Li Q., Gehrke L., Credo R.B., Warner R.B., Lee J.Y., Kovar P., Frost D., Ng S.C., and Sham H.L. Bioorg Med Chem Lett 11 (2001) 1671-1673
59. Shan B., Medina J.C., Santha E., et al. Proc Natl Acad Sci 96 (1999) 5686-5691
60. Rubenstein S.M., Baichwal V., Beckmann H., Clark D.L., Frankmoelle W., Roche D., Santha E., Schwender S., Thoolen M., Ye Q., and Jaen J.C. J Med Chem 44 (2001) 3599-3605
61. Ozawa Y., Sugi N.H., Nagasu T., Owa T., Watanabe T., Koyanagi N., Yoshino H., Kitoh K., and Yoshimatsu K. Eur J Cancer 37 (2001) 2275-2282
62. Shih H., Deng L., Carrera C.J., Adachi S., Cottam H.B., and Carson D.A. Bioorg Med Lett 10 (2000) 487-490
63. Leoni L.M., Hamel E., Genini D., Shih H., Carrera C.J., Cottam H.B., and Carson D.A. Journal of the National Cancer Institute 92 (2000) 217-224
64. Combeau C., Provost J., Lancelin F., Tournoux Y., Prod'homme F., Herman F., Lavelle F., Leboul J., and Vuilhorgne M. Mol Pharmacol 57 (2000) 553-563
65. Jan S.T., Mao C., Vassilev A.O., Navara C.S., and Uckun F.M. Bioorg Med Chem Lett 70 (2000) 1193-1197
66. Huang H., Mao C., Jan S.T., and Uckun F.M. Tetrahedron Lett 41 (2000) 1699-1702
67. Uckun F.M., Mao C., Vassilev A.O., Huang H., and Jan S.T. Bioorg Med Chem Lett 10 (2000) 541-545
68. Bai R., Taylor G.F., Cichacz Z.A., Herald C.L., Kepler J.A., Pettit G.R., and Hamel E. Biochemistry 34 (1995) 9714-9721
69. Jacquesy J.C., and Fahy J. In: Torrance P.F. (Ed). Biomedical Chemistry: Applying Chemical Principles to the Understanding and Treatment of Disease - Cancer: Superacid Generation of New Antitumor Agents (2000), John Wiley & Sons, Inc., London 227-246
70. Campone M., Fumoleau P., Delecroix V., Deporte-Fety R., Perrocheau G., Vernillet L., Borg-Olivier O., Louboutin J.P., Bissery M.C., Riva A., and Azli N. Annals of Oncology 12 (2001) 909-918
71. Hill B.T., Fiebig H.H., Waud W.R., Poupon M.F., Colpaert F., and Kruczynski A. Eur J Cancer 35 (1999) 512-520
72. Kruczynski A., and Hill B.T. Crit Rev Oncol Hematol 40 (2001) 159-173
73. Abstract 576. Fumoleau P., et al. Clin Cancer Res 6 (Suppl.) (2000)
74. Eggen M., and Georg G.I. Med Res Rev 22 (2002) 85-101
75. Panda D., Ananthnarayan V., Larson G., Shih C., Jordan M.A., and Wilson L. Biochemistry 39 (2000) 14121-14127
76. Liang J., Moher E.D., Moore R.E., and Hoard D.W. J Org Chem 65 (2000) 3143-3147
77. Patel V.F., Andis S.L., Kennedy J.H., Ray J.E., and Schultz R.M. J Med Chem 42 (1999) 2588-2603
78. Wagner M.M., Paul D.C., Shih C., Jordan M.A., Wilson L., and Williams D.C. Cancer Chemother Pharmacol 43 (1999) 115-125
79. Sessa C., Weigang-Köhler K., Pagani O., Greim G., Mor O., De Pas T., Burgess M., Weimer I., and Johnson R. Eur J Cancer 38 (2002) 2388-2396
80. Abstract 167. Groth G., et al. Eur J Cancer 37 (Suppl. 6) (2001)
81. Pettit G.R., Kamano Y., Herald C.L., Tuinman A.A., Boettner F.E., Kizu H., Schmidt J.M., Baczynskyj L., Tomer K.B., and Bontems R.J. J Am Chem Soc 109 (1987) 6883-6885
82. Bai R., Petit G.R., and Hamel E. Biochem Pharmacol 39 (1990) 1941-1949
83. Pitot H.C., Mcelroy Jr. E.A., Reid J.M., Windebank A.J., Sloan J.A., Erlichman C., Bagniewski P.G., Walker D.L., Rubin J., Goldberg R.M., Adjei A.A., and Ames M.M. Clin Cancer Res 5 (1999) 525-531
84. Vaishampayan U., Glode M., Du W., Kraft A., Hudes G., Wright J., and Hussain M. Clin Cancer Res 6 (2000) 4205-4208
85. Saad E.D., Kraut E.H., Hoff P.M., Moore Jr. D.F., Jones D., Pazdur R., and Abbruzzese J.L. Am J Clin Oncol 25 (2002) 451-453
86. Jordan M.A., Walker D., Arruda M., Barlozzari T., and Panda D. Biochemistry 37 (1998) 17571-17578
87. De Arruda M., Cocciaro C.A., Nelson C.M., Grinnell C.M., Janssen B., Haupt A., and Barlozzari T. Cancer Research 55 (1995) 3085-3092
88. th Ann Us Piper J affray Healthcare Conf. New York (2004)
89. Villalona-Calero M.A., Baker S., Hammond L., Aylesworth C., Eckhardt S.G., Kraynak M., Fram R., Fischkoff S., Velagapudi R., Toppmeyer D., Razvillas B., Jakimowicz K., Von Hoff b., and Rowinsky E. J Clin Oncology 16 (1998) 2770-2779
90. Smyth J., Boneterre M.E., Schellens J., Calvert H., Greim G., Wanders J., and Hanauske A. Annals of Oncology 12 (2001) 509-511
91. Abstract 414. Michaelson, et al. ACSO Annual Meeting (2002)
92. Nicoletti M.I., Colombo T., Rossi C., Monardo C., Stura S., Zucchetti M., Riva A., Morazzoni P., Donati M.B., Bombardelli E., D'Incalci M., and Giavazzi R. Cancer Res 60 (2000) 842-846
93. Georgoulias V. Curr Med Chem 9 (2002) 869-877
94. Bissery M.C. Curr Pharm Design 7 (2001) 1251-1257
95. Hidalgo M., Aylesworth C., Hammond L.A., Britten C.D., Weiss G., Stephenson Jr. J., Schwartz G., Patnaik A., Smith L., Molpus K., Felton S., Gupta E., Ferrante K.J., Tortora A., Sonnichsen D.S., Skillings J., and Rowinsky E.K. J Clin Oncol 19 (2001) 2493-2503
96. Altstadt T.J., Fairchild C.R., Golik J., Johnston K.A., Kadow J.F., Lee F.Y., Long B.H., Rose W.C., Vyas D.M., Wong H., Wu M.J., and Wittman M.D. J Med Chem 44 (2001) 4577-4583
97. ASCO Meeting (2002)
98. Gelmon K.A., Latreille J., Tolcher A., Genier L., Fisher B., Forand D., D'Aloisio S., Vernillet L., Daigneault L., Lebecq A., Besenval M., and Eisenhauer E. J Clin Oncol 18 (2000) 4098-4108
99. (Abstract). Dykes D.J., Sarsat J.P., and Bissery M.C. Proc Am Assoc Cancer Res 41 (2000) 301
100. Distefano M., Scambia G., Ferlini C., Gaggini C., De Vincenzo R., Riva A., Bombardelli E., Ojima I., Fattorossi A., Panici P.B., and Mancuso S. Int J Cancer 72 (1997) 844-850
101. Polizzi D., Pratesi G., Monestiroli S., Tortoreto M., Zunino F., Bombardelli E., Riva A., Morazzoni P., Colombo T., D'Incalci M., and Zucchetti M. Clin Cancer Res 6 (2000) 2070-2074
102. th Eur Cancer Conf. Copenhagen (2003)
103. Ojima I., Kuduk S., Chakravarty S., Lin S., Wang T., Geng X., et al. ACS Symposium Series (Anticancer Agents) 796 (2001) 59-80
104. Damen E., Nevalainen T.P., van den Bergh T.J.M., de Groot F.M.H., and Scheeren H.W. Bioorganic Med Chem 10 (2002) 71-77
105. ter Haar E., Kowalski R.J., Hamel E., Lin C.M., Longley R.E., Gunasekera S.P., Rosenkranz H.S., and Day B.W. Biochemistry 35 (1996) 243-250
106. Giannakakou P., and Fojo T. Clin Cancer Res 6 (2000) 1613-1615
107. Kowalski R.J., Giannakakou P., Gunasekera S.P., Longley R.E., Day B.W., and Hamel E. Mol Pharmacol 52 (1997) 613-622
108. Martello L.A., McDaid H.M., Regl D.L., Yang C.P., Meng D., Pettus T.R., Kaufman M.D., Arimoto H., Danishefsky S.J., Smith III A.B., and Horwitz S.B. Clin Cancer Res 6 (2000) 1978-1987
109. Hoefle G., Bedorf N., Steinmetz H., Schomburg D., Gerth K., and Reichenbach H. Angew Chem Int Ed Engl 35 (1996) 1567-1569
110. Bollag D.M., Mcqueney P.A., Zhu J., Hensens O., Koupal L., Liesch J., Goetz M., Lazarides E., and Woods C.M. Cancer Res 55 (1995) 2325-2333
111. Muhlradt P.F., and Sasse F. Cancer Res 57 (1997) 3344-3346
112. Abstract 575. Calvert P.M., et al. EORTC Meeting Amsterdam (2002)
113. R&D Day, Novartis (2003)
114. 14th EORTC-NCI-AACR Symp Molec Targets Cancer Ther. Frankfurt (2002)
115. Lee F.Y., Borzilleri R., Fairchild C.R., Kim S.H., Long B.H., Reventos-Suarez C., Vite G.D., Rose W.C., and Kramer R.A. Clin Cancer Res 7 (2001) 1429-1437
116. Giannakakou P., Sackett D.L., Kang Y.K., Zhan Z., Buters J.T., Fojo T., and Poruchynsky M.S. J Biol Chem 272 (1997) 17118-17125
117. Abstract 775. Fojo A.T., et al. AACR-NCI-EORTC Conference. Miami (2002)
118. Mcdaid H.M., Mani S., Shen H.J., Muggia F., Sonnichsen D., and Horwitz S.B. Clin Cancer Res 5 (2002) 2035-2043
119. Hamel E., Sackett D.L., Vourloumis D., and Nicolaou K.C. Biochemistry 38 (1999) 5490-5498
120. Nicolaou K.C., Pfefferkorn J., Xu J., Winssinger N., Ohshima T., Kim S., Hosokawa S., Vourloumis D., van Delft F., and Li T. Chem Pharm Bull (Tokyo) 47 (1999) 1199-1213
121. Long B.H., Carboni J.M., Wasserman A.J., Cornell L.A., Casazza A.M., Jensen P.R., Lindel T., Fenical W., and Fairchild C.R. Cancer Res 58 (1998) 1111-1115